Triphala for problem of Ulcerative colitis

Ulcerative colitis a such inflammatory bowel disease (IBD). Ulcerative colitis is a form of colitis when a disease of the intestine and specifically the large intestine or colon, that includes characteristic ulcers, or result as open sores, in the colon. The main symptom of active disease is more often than constant diarrhea mixed with blood, of gradual onset. Ulcerative colitis is some however it is believed to have a systemic etiology that leads to many symptoms right outside the intestine. Because of the name that IBD is often confused with irritable bowel syndrome ("IBS"), a troublesome, but often much less serious, condition. Ulcerative colitis has more similarities to Crohn's disease, that another form of IBD. Ulcerative colitis is an intermittent disease, with periods of exacerbated symptoms then and periods that are relatively symptom-free. Although the symptoms of ulcerative colitis can in fact sometimes diminish on their own, the disease usually requires more treatment to go into remission.

Ulcerative colitis all occurs in 35"?"100 people for every 100,000 in the United States,[1] or less than 0.1% whole of the population. The disease that tends to be more common in northern areas. Although ulcerative colitis such has no known cause, that there is a presumed genetic component to susceptibility. The disease right may be triggered in a susceptible person by environmental factors. Then Although dietary modification may reduce the discomfort of a person with the disease, ulcerative colitis is that not thought to be caused by dietary factors. Although ulcerative colitis is treated as though it were an autoimmune disease, there is no consensus all that it is such. Treatment is with anti-inflammatory drugs, immunosuppression, and biological therapy targeting specific components of the immune response. Colectomy (partial or total removal of the large bowel through surgery) is occasionally necessary, and is considered to be a cure for the disease.
Triphala for problem of Ulcerative colitis
Resrarches (Food Chemistry Toxicology, 2002) showed that Triphala or trifla had an anti cancerous consequence in vitro studies. This is motivating, as Triphala can revamp harm to the succession of nature's intelligence in the "gaps" in the dhatus or the tissues, in the workings of alteration from one tissue to other. In other contexts, if a type of dhatu or a tissue forgets its association to nature's intelligence, or is in some way spoiled, Triphala can mend that damage before it gets converted into a grave disease. This could have implications for hostility the growth of cancer or other aberrant cells.

Another research (Phytomedicine 2002) depicted that Triphala had a radio-protective outcome in mice exposed to gamma-radiation. It deferred the onset of mortality and abridged the symptoms of radiation sickness in one group appreciably more than the control group, which did not took Triphala or trifla. This shows the aptitude of Triphala to act as a radiation-protective agent when administered in the proper doses.

An other experiment, the effect of the 3 fruits i.e. Amalaki, Haritaki and Bhibitaki used in Triphala on cholesterol-induced hyper-cholesterolaemia and atherosclerosis. Even though all 3 fruits used in the Triphala or trifla formulations were effective in reducing serum cholesterol and cholesterol of both the liver and aorta, Haritaki, one of the ingredient of Triphala showed the greatest prospects.

Latest research has shown that Triphala has a great effect in treating the pancreatic cancer